Connect your AI

Nuvation Bio NUVB Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Nuvalent, Inc.NUVL

$10.14M+123%

ImmunomeIMNM

$229K+7.5%

ArriVent BioPharma, Inc.AVBP

$54.72M+740%

Arcus BiosciencesRCUS

$0-100%

IDEAYA Biosciences, Inc.IDYA

$1.19M+4.9%

ImmunityBio, Inc.IBRX

$971K+341%

Other financials

Income statement

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nuvation Bio's stock issuance proceeds?: Nuvation Bio (NUVB) reported stock issuance proceeds of $908K in Q1 2026.
How has Nuvation Bio's stock issuance proceeds changed year-over-year?: Nuvation Bio's stock issuance proceeds decreased by 16.1% year-over-year, from $1.08M to $908K.
What is the long-term trend for Nuvation Bio's stock issuance proceeds?: Over 2 years (2022 to 2025), Nuvation Bio's stock issuance proceeds has grown at a 228.1% compound annual growth rate (CAGR), from $939K to $10.11M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.